捕捉布普伦诺芬治疗反应的全方位范围
Allen J Bailey1, Victoria R Votaw1, Roger D Weiss1
1Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts.
JAMA psychiatry
|December 4, 2024
概括
布普伦诺芬加医疗咨询 (BUP+MC) 在阿片类药物使用障碍 (OUD) 患者中显著减少了非法阿片类药物的使用. 许多患者表现出明显的改善,即使他们没有完全戒断.
科学领域:
- 成 药物 药物 药物 药物
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于戒断的标准可能不能完全代表阿片类药物使用障碍 (OUD) 的治疗有效性.
- 布普伦诺芬加医疗咨询 (BUP+MC) 是OUD的关键治疗方法.
研究的目的:
- 分析BUP+MC.MC.治疗OUD患者的非法阿片类药物使用减少模式.
- 为了评估治疗反应超出严格的戒断标准.
主要方法:
- 对4项协调随机临床试验的二次分析,涉及869名OUD患者.
- 每周自我报告的非法阿片类药物使用数据收集了超过12周的数据.
- 通过尿液药物查证实了禁欲.
主要成果:
- 到第12周,只有43%的患者满足了基于禁欲的成功标准.
- 总体样本显示,非法阿片类药物使用显著减少,从每周约6.2天降至每周约0.5天.
- 不符合戒断标准的患者仍然显示使用量大幅减少.
结论:
- BUP+MC导致阿片类药物使用的显著减少,许多患者实现了部分反应.
- 目前基于禁欲的指标可能低估了BUP+MC的有效性.
- 需要进一步的研究来将减少的使用与功能性结果联系起来.
相关概念视频
Dose-Response Relationship: Overview
3.0K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.0K
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
223
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
223
Dose-Response Relationship: Potency and Efficacy
4.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.2K
Drug Administration and Therapy Phases: Overview
409
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
409


